Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202147316> ?p ?o ?g. }
- W3202147316 endingPage "1098" @default.
- W3202147316 startingPage "1085" @default.
- W3202147316 abstract "Availability of new classes of novel agents has led to a radical switch in treatment paradigms for newly diagnosed transplant-ineligible multiple myeloma (NDTIMM) patients, providing an opportunity to significantly enhance the depth of response and extend survival outcomes.Treatment regimens including proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs) and/or monoclonal antibodies (mAbs), have achieved recent regulatory approval for NDTIMM, while novel combinations and newer agents are currently being explored. This review discusses the current landscape and possible treatment development of NDTIMM.Bortezomib-lenalidomide-dexamethasone (VRd), daratumumab-bortezomib-melphalan-prednisone (DaraVMP) and daratumumab-lenalidomide-dexamethasone (DaraRd) represent new standard of care (SOC) treatments for NDTIMM patients, based on phase III trials showing their superior efficacy as compared with previous SOCs. The possibility of improving results by incorporating second generation PIs or using quadruple regimens has also been explored and different trials are still ongoing. Newer agents and innovative immunotherapies targeting B-cell maturation antigen have the potential to change the therapeutic landscape in coming years. Personalized approaches based on frailty-adapted, risk-based and minimal residual disease driven paradigms are under investigation." @default.
- W3202147316 created "2021-10-11" @default.
- W3202147316 creator A5040474758 @default.
- W3202147316 creator A5042966800 @default.
- W3202147316 creator A5051226797 @default.
- W3202147316 creator A5051368482 @default.
- W3202147316 creator A5053593793 @default.
- W3202147316 creator A5055543156 @default.
- W3202147316 creator A5071926851 @default.
- W3202147316 creator A5072734499 @default.
- W3202147316 date "2021-10-04" @default.
- W3202147316 modified "2023-09-27" @default.
- W3202147316 title "Emerging and current treatment combinations for transplant-ineligible multiple myeloma patients" @default.
- W3202147316 cites W1585625390 @default.
- W3202147316 cites W1898969431 @default.
- W3202147316 cites W1969110349 @default.
- W3202147316 cites W1985864219 @default.
- W3202147316 cites W2000815213 @default.
- W3202147316 cites W2016742872 @default.
- W3202147316 cites W2020298011 @default.
- W3202147316 cites W2048483323 @default.
- W3202147316 cites W2096207943 @default.
- W3202147316 cites W2106692847 @default.
- W3202147316 cites W2110466835 @default.
- W3202147316 cites W2114396320 @default.
- W3202147316 cites W2117887415 @default.
- W3202147316 cites W2120780398 @default.
- W3202147316 cites W2134902298 @default.
- W3202147316 cites W2141105112 @default.
- W3202147316 cites W2142149038 @default.
- W3202147316 cites W2158106888 @default.
- W3202147316 cites W2169183166 @default.
- W3202147316 cites W2182681254 @default.
- W3202147316 cites W2193716145 @default.
- W3202147316 cites W2201190784 @default.
- W3202147316 cites W2318069817 @default.
- W3202147316 cites W2343386476 @default.
- W3202147316 cites W2344906871 @default.
- W3202147316 cites W2400276917 @default.
- W3202147316 cites W2512106959 @default.
- W3202147316 cites W2528329272 @default.
- W3202147316 cites W2567188480 @default.
- W3202147316 cites W2613844594 @default.
- W3202147316 cites W2769593282 @default.
- W3202147316 cites W2772566228 @default.
- W3202147316 cites W2784152305 @default.
- W3202147316 cites W2802890120 @default.
- W3202147316 cites W2806499269 @default.
- W3202147316 cites W2914566915 @default.
- W3202147316 cites W2918412728 @default.
- W3202147316 cites W2919022600 @default.
- W3202147316 cites W2943335541 @default.
- W3202147316 cites W2947874495 @default.
- W3202147316 cites W2955020974 @default.
- W3202147316 cites W2969287051 @default.
- W3202147316 cites W2969931905 @default.
- W3202147316 cites W2977561477 @default.
- W3202147316 cites W2995934717 @default.
- W3202147316 cites W2996752315 @default.
- W3202147316 cites W3009453334 @default.
- W3202147316 cites W3012570191 @default.
- W3202147316 cites W3022297454 @default.
- W3202147316 cites W3022981424 @default.
- W3202147316 cites W3032142108 @default.
- W3202147316 cites W3036660876 @default.
- W3202147316 cites W3049547584 @default.
- W3202147316 cites W3082053425 @default.
- W3202147316 cites W3087836559 @default.
- W3202147316 cites W3092622634 @default.
- W3202147316 cites W3093491172 @default.
- W3202147316 cites W3094996259 @default.
- W3202147316 cites W3096445279 @default.
- W3202147316 cites W3096538903 @default.
- W3202147316 cites W3096867320 @default.
- W3202147316 cites W3111394247 @default.
- W3202147316 cites W3113412439 @default.
- W3202147316 cites W3118578165 @default.
- W3202147316 cites W3127065235 @default.
- W3202147316 cites W3136388199 @default.
- W3202147316 cites W3136849454 @default.
- W3202147316 cites W3158234499 @default.
- W3202147316 cites W3167608264 @default.
- W3202147316 cites W3180549397 @default.
- W3202147316 cites W3209897673 @default.
- W3202147316 cites W4248774277 @default.
- W3202147316 cites W4293087945 @default.
- W3202147316 doi "https://doi.org/10.1080/17474086.2021.1983426" @default.
- W3202147316 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34602012" @default.
- W3202147316 hasPublicationYear "2021" @default.
- W3202147316 type Work @default.
- W3202147316 sameAs 3202147316 @default.
- W3202147316 citedByCount "1" @default.
- W3202147316 countsByYear W32021473162023 @default.
- W3202147316 crossrefType "journal-article" @default.
- W3202147316 hasAuthorship W3202147316A5040474758 @default.
- W3202147316 hasAuthorship W3202147316A5042966800 @default.
- W3202147316 hasAuthorship W3202147316A5051226797 @default.
- W3202147316 hasAuthorship W3202147316A5051368482 @default.